Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Loss of Raf kinase inhibitor protein expression is associated with human papillomavirus 16 infection in anal tumors

Full text
Author(s):
Show less -
Bidinotto, Lucas Tadeu [1, 2] ; Veo, Carlos A. R. [1] ; Loaiza, Edgar Aleman [1] ; Ribeiro, Guilherme G. [1] ; Lorenzi, Adriana T. [1] ; Reis Rosa, Luciana Albina [3] ; de Oliveira, Cristina Mendes [3] ; Levi, Jose Eduardo [3] ; Scapulatempo-Neto, Cristovam [4, 1] ; Longatto-Filho, Adhemar [1, 5, 6] ; Reis, Rui Manuel [1, 5, 6]
Total Authors: 11
Affiliation:
[1] Barretos Canc Hosp, Mol Oncol Res Ctr, 1331 Antenor Duarte Villela, BR-14784400 Barretos, SP - Brazil
[2] Dr Paulo Prata FACISB, Barretos Sch Hlth Sci, Human & Expt Biol Dept, BR-14785002 Barretos, SP - Brazil
[3] Univ Sao Paulo, Inst Trop Med, Lab Virol, BR-05403000 Sao Paulo, SP - Brazil
[4] Barretos Canc Hosp, Dept Pathol, BR-14784400 Barretos, SP - Brazil
[5] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, P-4704553 Braga - Portugal
[6] Portugal Govt Associate Lab, Res Grp, Biomat Biodegradables & Biomimet 3Bs, P-4806909 Braga - Portugal
Total Affiliations: 6
Document type: Journal article
Source: Oncology Letters; v. 16, n. 2, p. 1785-1790, AUG 2018.
Web of Science Citations: 0
Abstract

There has been an increase in the incidence of anal cancer in the past two decades, with squamous cell carcinoma (SCC) being the most frequent histological type identified. Among the risk factors, high-risk human papillomavirus (HPV) infection is the most pervasive. Raf kinase inhibitor protein (RKIP) is expressed in a number of normal human tissues and previous studies have demonstrated the prognostic value of the loss of RKIP expression in several gastrointestinal tumors. Therefore, the present study aimed to evaluate the clinical implications of RKIP expression in a series of neoplastic lesions of the anal canal. The resected tumors of 48 patients {[}8 high-grade intraepithelial lesions (HSILs), 14 adenocarcinomas and 26 squamous cell carcinomas (SCCs)] were immunohistochemically evaluated for RKIP expression, and the results were correlated with clinicopathological data. The results identified a decreased 5-year overall survival rate in patients with adenocarcinoma (40.8%) compared with patients with SCC (76.7%), and a decreased 5-year disease-free survival rate in patients at clinical stages III/IV (37.3 vs. 62.5 and 82.6% for clinical stages 0 and I/II, respectively). Low RKIP expression was revealed in 62.5% of HSILs, 88.5% of SCCs and 100.0% of the adenocarcinomas. High RKIP expression was associated with patient ethnicity (37.5% in non-Caucasians vs. 7.5% in Caucasians) and patient age (33.3% in younger patients vs. 0.0% in older patients). Finally, high RKIP expression was correlated with HPV16 infection status (40% in HPV- vs. 5.3% in HPV+ patients). A correlation was identified between high RKIP expression and lesions with a generally improved prognosis, such as those diagnosed in younger patients, in situ lesions and lesions of lower clinical grades; there was also a negative correlation between high RKIP expression and HPV16 positivity in patients. (AU)

FAPESP's process: 10/16795-4 - HPV biomarkers screening in anal swab: correlation with cervix, oral and oropharyngeal infections
Grantee:Adhemar Longatto Filho
Support Opportunities: Regular Research Grants
FAPESP's process: 11/08523-7 - Chromosomal alterations profiling in brain tumors (medulloblastomas and gliomas): the impact in the identification of new tumorigenic pathways
Grantee:Lucas Tadeu Bidinotto
Support Opportunities: Scholarships in Brazil - Post-Doctoral